Works matching IS 17762596 AND DT 2020 AND VI 15 AND IP 2

Results: 10

Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.

Published in:

2020

By:

Ramanathan, Ramesh K.;
Von Hoff, Daniel D.;
Eskens, Ferry;
Blumenschein, George;
Richards, Donald;
Genvresse, Isabelle;
Reschke, Susanne;
Granvil, Camille;
Skubala, Adam;
Peña, Carol;
Mross, Klaus;
Blumenschein, George Jr

Publication type:

journal article

Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients.

Published in:

2020

By:

Kim, Jinchul;
Byeon, Seonggyu;
Kim, Hyera;
Yeo, Ja Hyun;
Hong, Jung Yong;
Lee, Jeeyun;
Lim, Ho Yeong;
Kang, Won Ki;
Kim, Seung Tae

Publication type:

journal article

Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer.

Published in:

2020

By:

Cho, Yong-Hee;
Choi, Myeong Geun;
Kim, Dong Ha;
Choi, Yun Jung;
Kim, Seon Ye;
Sung, Ki Jung;
Lee, Jae Cheol;
Kim, Sang-Yeob;
Rho, Jin Kyung;
Choi, Chang-Min

Publication type:

research

Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond.

Published in:

2020

By:

Choi, Jun H.;
Bogenberger, James M.;
Tibes, Raoul

Publication type:

journal article

Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib.

Published in:

2020

By:

Jiang, Shiyu;
Qin, Yan;
Gui, Lin;
Liu, Peng;
Jiang, Hongxin;
Liu, Biao;
Yang, Jianliang;
Yang, Sheng;
He, Xiaohui;
Zhou, Shengyu;
Du, Xinhua;
Yi, Yuting;
Lin, Jing;
Shi, Yuankai

Publication type:

journal article

Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model.

Published in:

2020

By:

Ramsey, Haley E.;
Oganesian, Aram;
Gorska, Agnieszka E.;
Fuller, Londa;
Arrate, Maria;
Boyd, Kelli;
Keer, Harold;
Azab, Mohammad;
Savona, Michael R.

Publication type:

journal article

Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study.

Published in:

2020

By:

Lou, Yuqing;
Xu, Jianlin;
Zhang, Yanwei;
Lu, Jun;
Chu, Tianqing;
Zhang, Xueyan;
Wang, Huimin;
Zhong, Hua;
Zhang, Wei;
Han, Baohui

Publication type:

journal article

Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma.

Published in:

2020

By:

Sheng, Iris Y.;
Diaz-Montero, Claudia Marcela;
Rayman, Patricia;
Wei, Wei;
Finke, James H.;
Kim, Jin S.;
Pavicic, Paul G.;
Lamenza, Marcelo;
Company, Donna;
Stephenson, Andrew;
Campbell, Steven;
Haber, George;
Lee, Byron;
Mian, Omar;
Gilligan, Timothy D.;
Rini, Brian I.;
Garcia, Jorge A.;
Grivas, Petros;
Ornstein, Moshe C.;
Pavicic, Paul G Jr

Publication type:

journal article

Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study.

Published in:

2020

By:

Byeon, Seonggyu;
Hong, Jung Yong;
Lee, Jeeyun;
Nam, Do-Hyun;
Park, Se Hoon;
Park, Joon Oh;
Park, Young Suk;
Lim, Ho Yeong;
Kang, Won Ki;
Kim, Seung Tae

Publication type:

journal article

Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice.

Published in:

2020

By:

Buchler, Tomas;
Kiss, Igor;
Hornova, Jana;
Fiala, Ondrej;
Wiesnerova, Marketa;
Svoboda, Michal;
Silar, Jiri;
Kopeckova, Katerina;
Poprach, Alexandr;
Finek, Jindrich;
Petruzelka, Lubos;
Melichar, Bohuslav

Publication type:

journal article